Abstract:Abstract Introduction: Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and vascular function. The mechanisms of VEGF signaling in angiogenesis have been extensively studied. However, its effects on tumor cell function remain to be elucidated. Our studies on depletion of VEGF by somatic knockout of the VEGF gene or by siRNA in human colorectal cancer (CRC) cell lines have demonstrated that loss of VEGF expression led to significantly decreased cell growth, increased apoptosis, and enhanced chemo-sensitivity of CRC cells through an intracrine signaling mechanism. These intracrine effects were mediated through VEGF by regulation of the activity of multiple receptor tyrosine kinases (e.g. EGFR, cMET) and downstream AKT signaling. Similar effects were observed by depletion of VEGF receptor 1 (VEGFR1), supporting the role of a novel intracellular VEGF-VEGFR1 complex in CRC cell survival. Since VEGF signaling has been shown to effect endothelial and tumor cell migration, we attempted to determine if inhibition of intracrine VEGF signaling affected CRC cell motility. Methods: Migration and invasion of CRC cells, with and without VEGF depletion, were assayed using Boyden chambers and a serum gradient. Changes in cell morphology and epithelial to mesenchymal transition (EMT) markers and markers of cell motility were assessed by microscopy, immunostaining, and western blot analyses. Results: Depletion of VEGF by siRNAs in multiple CRC cell lines led to a very strong inhibition of migration and invasion of CRC cells. Such inhibition was not observed when CRC cells were treated with bevacizumab to inhibit paracrine or autocrine signaling. Further examination revealed no significant changes in cell morphology. Other than Twist, there were no significant differences between specific markers of EMT indicating that differences in migration and invasion were not due to classic alterations in EMT. However, significant changes in activation of mediators of cell motility were observed. VEGF depleted CRC cells demonstrated significantly lower levels of phosphorylated focal adhesion kinase (p-FAK) compared to cells with normal VEGF expression. Analyses of upstream regulators indicated strong reduction in either p-cMET or p-SRC depending on cell type. Conclusions: Inhibition of intracrine VEGF signaling strongly inhibits CRC cell migration and invasion by regulating proteins involved in cell motility. Citation Format: Rajat Bhattacharya, Ling Xia, Fan Fan, Rui Wang, Delphine Boulbes, Xiang-Cang Ye, Lee Ellis. Inhibition of intracrine VEGF signaling prevents colorectal cancer cell migration and invasion. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 3255.

Distinct Roles of VEGFR-1 and VEGFR-2 in the Aberrant Hematopoiesis Associated with Elevated Levels of VEGF.

Abstract 365: Autocrine Vascular Endothelial Growth Factor Signaling Mediates Survival and Chemoresistance of Human Colorectal Cancer Cells

Abstract 5132: Hypo-glycosylation of Vascular Endothelial Growth Factor Receptor-1 May Contribute to Intracrine Signaling in Human Colorectal Cancer Cells

Abstract 3255: Inhibition of Intracrine VEGF Signaling Prevents Colorectal Cancer Cell Migration and Invasion

Endothelial CDS2 deficiency causes VEGFA-mediated vascular regression and tumor inhibition

A Critical Role of VEGFR2 in Lymphatic Tumor Metastasis

The Role and Significance of VEGFR2+ Regulatory T Cells in Tumor Immunity.

Vascular endothelial growth factor receptor-2 in breast cancer.

Role of VEGFs/VEGFR-1 Signaling and Its Inhibition in Modulating Tumor Invasion: Experimental Evidence in Different Metastatic Cancer Models

Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role

Genetic Inhibition Of Vascular Endothelial Growth Factor Receptor-1 Significantly Inhibits The Migration And Proliferation Of Leukemia Cells And Increases Their Sensitivity To Chemotherapy

Up-Regulation Of Vegf And Its Receptor In Refractory Leukemia Cells

Impaired tumor growth and angiogenesis in mice heterozygous for Vegfr2 (Flk1)

Expression and role of vascular endothelial growth factor and its receptors in acute myeloid leukemia with normal cytogenetics

EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models

Tumor-derived Vascular Endothelial Growth Factor (Vegf)-a Facilitates Tumor Metastasis Through the VEGF-VEGFR1 Signaling Pathway.

VEGFR2 Regulates Endothelial Differentiation of Colon Cancer Cells

VEGF-B Promotes Cancer Metastasis Through a VEGF-A–independent Mechanism and Serves As a Marker of Poor Prognosis for Cancer Patients

VEGF-C, VEGF-D, and VEGFR-3 and their roles in lymphatic metastasis of tumors

VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

The Role of Heterodimerization Between VEGFR-1 and VEGFR-2 in the Regulation of Endothelial Cell Homeostasis